{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:01:42Z","timestamp":1770742902698,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10620-024-08811-0","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T02:46:13Z","timestamp":1735872373000},"page":"719-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018\u20132023"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-5877","authenticated-orcid":false,"given":"Angela J.","family":"Forbes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-7386","authenticated-orcid":false,"given":"Andrew S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0603-5661","authenticated-orcid":false,"given":"Chris M. A.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2298-5141","authenticated-orcid":false,"given":"Richard B.","family":"Gearry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"8811_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nature Reviewws Gastroenterology and Hepatology. 2015;12:205\u2013217.","journal-title":"Nature Reviewws Gastroenterology and Hepatology."},{"key":"8811_CR2","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390:2769\u20132778.","journal-title":"The Lancet."},{"key":"8811_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nature Reviewws Gastroenterology and Hepatology. 2021;18:56\u201366.","journal-title":"Nature Reviewws Gastroenterology and Hepatology."},{"key":"8811_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, Soon S, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46\u201354.","journal-title":"Gastroenterology."},{"key":"8811_CR5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/MIB.0000000000000161","volume":"20","author":"GG Kaplan","year":"2014","unstructured":"Kaplan GG. Pitfalls and perils of using administrative databases to evaluate the incidence of inflammatory bowel disease overtime. Inflammatory Bowel Disease. 2014;20:1777\u20131779.","journal-title":"Inflammatory Bowel Disease."},{"key":"8811_CR6","first-page":"5A","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 montreal world congress of gastroenterology. Canadian Journal of Gastroenterology and Hepatology. 2005;19:5A-36A.","journal-title":"Canadian Journal of Gastroenterology and Hepatology."},{"key":"8811_CR7","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/ibd\/izad295","volume":"30","author":"AJ Forbes","year":"2024","unstructured":"Forbes AJ, Frampton CM, Day AS, Kaplan GG, Gearry RB. The epidemiology of inflammatory bowel disease in oceania: a systematic review and meta-analysis of incidence and prevalence. Inflammatory Bowel Diseases. 2024;30:2076\u20132086.","journal-title":"Inflammatory Bowel Diseases."},{"key":"8811_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MPG.0000000000003900","volume":"77","author":"AJ Forbes","year":"2023","unstructured":"Forbes AJ, Frampton CM, Day AS, Vernon-Roberts A, Gearry RB. Descriptive epidemiology of pediatric inflammatory bowel disease in Oceania: a systematic review and meta-analysis. Journal of Pediatric Gastroenterology and Nutrition. 2023;77:512\u2013518.","journal-title":"Journal of Pediatric Gastroenterology and Nutrition."},{"key":"8811_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.mib.0000231572.88806.b9","volume":"12","author":"RB Gearry","year":"2006","unstructured":"Gearry RB, Richardson A, Frampton CM et al. High incidence of Crohn\u2019s disease in Canterbury, New Zealand: results of an epidemiologic study. Inflammatory Bowel Disease. 2006;12:936\u2013943.","journal-title":"Inflammatory Bowel Disease."},{"key":"8811_CR10","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1097\/MIB.0000000000000829","volume":"22","author":"HY Su","year":"2016","unstructured":"Su HY, Gupta V, Day AS, Gearry RB. Rising incidence of inflammatory bowel disease in Canterbury New Zealand. Inflammatory Bowel Disease. 2016;22:2238\u20132244.","journal-title":"Inflammatory Bowel Disease."},{"key":"8811_CR11","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","volume":"135","author":"MD Kappelman","year":"2008","unstructured":"Kappelman MD, Rifas-Shiman SL, Porter CQ et al. Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907\u20131913.","journal-title":"Gastroenterology."},{"key":"8811_CR12","unstructured":"Statistics New Zealand. Subnational population projections DHB [accessed 26 Oct 2024]. Available from: https:\/\/tewhatuora.shinyapps.io\/populations-web-tool\/"},{"key":"8811_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser C, Sturm A, Vavricka SR et al. ECCO-ESGAR Guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn\u2019s and Colitis. 2019;13:144\u2013164.","journal-title":"Journal of Crohn\u2019s and Colitis."},{"key":"8811_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/00365528909091339","volume":"24","author":"JE Lennard-Jones","year":"1989","unstructured":"Lennard-Jones JE. Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 1989;24:2\u20136.","journal-title":"Scandinavian Journal of Gastroenterology."},{"key":"8811_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/00365521.2020.1839960","volume":"55","author":"K Krishnaprasad","year":"2020","unstructured":"Krishnaprasad K, Walsh A, Begun J et al. Crohn\u2019s colitis care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease. Scand Journal of Gastroenterology. 2020;55:1419\u20131426.","journal-title":"Scand Journal of Gastroenterology."},{"key":"8811_CR16","first-page":"1","volume":"9","author":"OB Ahmad","year":"2001","unstructured":"Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva: World Health Organization. 2001;9:1\u20134.","journal-title":"Geneva: World Health Organization."},{"key":"8811_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","volume":"8","author":"J Burisch","year":"2023","unstructured":"Burisch J, Zhao M, Odes S et al. The cost of inflammatory bowel disease in high-income settings: a lancet gastroenterology and hepatology commission. The Lancet Gastroenterology and Hepatology. 2023;8:458\u2013492.","journal-title":"The Lancet Gastroenterology and Hepatology."},{"key":"8811_CR18","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1093\/jcag\/gwad009","volume":"6","author":"ME Kuenzig","year":"2023","unstructured":"Kuenzig ME, Im JHB, Coward S et al. The 2023 impact of inflammatory bowel disease in Canada: indirect (individual and societal) and direct out-of-pocket costs. Journal of the Canadian Association of Gastroenterology. 2023;6:S16\u2013S22.","journal-title":"Journal of the Canadian Association of Gastroenterology."},{"key":"8811_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15941.","author":"A Flanagan","year":"2022","unstructured":"Flanagan A, Allsopp SM, O\u2019Connor SA et al. High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region. Internal Medicine Journal. 2022. https:\/\/doi.org\/10.1111\/imj.15941.","journal-title":"Internal Medicine Journal"},{"key":"8811_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/imj.14111","volume":"49","author":"R Bhatia","year":"2019","unstructured":"Bhatia R, Yeoh SW, Vaz K et al. Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania Australia. Internal Medicine of Journal. 2019;49:622\u2013630.","journal-title":"Internal Medicine of Journal."},{"key":"8811_CR21","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1111\/imj.16072","volume":"53","author":"S Seleq","year":"2023","unstructured":"Seleq S, Weilert F, Fulforth J. Inflammatory bowel disease in Waikato, New Zealand: incidence and prevalence. Internal Medicine Journal. 2023;53:2307\u20132312.","journal-title":"Internal Medicine Journal."},{"key":"8811_CR22","first-page":"99","volume":"135","author":"M Qiu","year":"2022","unstructured":"Qiu M, Patel RN, Kerrison C, Gearry RB. Low but increasing rates of inflammatory bowel disease in Maori: a report from Lakes district health board IBD. N Z Med J. 2022;135:99\u2013105.","journal-title":"N Z Med J."},{"key":"8811_CR23","doi-asserted-by":"publisher","first-page":"175628482311975","DOI":"10.1177\/17562848231197509","volume":"16","author":"AT Elford","year":"2023","unstructured":"Elford AT, Leong RW, Halmos EP et al. IBD barriers across the continents: a continent-specific analysis\u2014Australasia. Therapeutic Advances in Gastroenterology. 2023;16:17562848231197508.","journal-title":"Therapeutic Advances in Gastroenterology."},{"key":"8811_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/gut.2005.085464","volume":"55","author":"RB Gearry","year":"2006","unstructured":"Gearry RB, Lea RA, Roberts RL et al. CARD15 allele frequency differences in New Zealand Maori: ancestry specific susceptibility to Crohn\u2019s disease in New Zealand? Gut. 2006;55:580.","journal-title":"Gut."},{"key":"8811_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ibd\/izab096","volume":"28","author":"JN Pena-Sanchez","year":"2022","unstructured":"Pena-Sanchez JN, Osei JA, Marques Santos JD et al. Increasing prevalence and stable incidence rates of inflammatory bowel disease among first nations: population-based evidence from a western Canadian province. Inflammatory Bowel Diseases. 2022;28:514\u2013522.","journal-title":"Inflammatory Bowel Diseases."},{"key":"8811_CR26","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1053\/j.gastro.2021.12.282","volume":"162","author":"ME Kuenzig","year":"2022","unstructured":"Kuenzig ME, Fung SG, Marderfeld L et al. Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: systematic review. Gastroenterology. 2022;162:e4.","journal-title":"Gastroenterology."},{"key":"8811_CR27","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1053\/j.gastro.2022.07.062","volume":"163","author":"M Agrawal","year":"2022","unstructured":"Agrawal M, Christensen HS, Bogsted M, Colombel JF, Jess T, Allin KH. The rising burden of inflammatory bowel disease in denmark over two decades: a nationwide cohort study. Gastroenterology. 2022;163:e5.","journal-title":"Gastroenterology."},{"key":"8811_CR28","unstructured":"Sarter H, Cr\u00e9tin T, Savoye G, Fumery M, Leroyer A, Dauchet L, et al. Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study. The Lancet Regional Health - Europe. 2024;47."},{"key":"8811_CR29","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/imj.16416","volume":"54","author":"D Law","year":"2024","unstructured":"Law D, Patel R, Gearry R et al. Phenotypes of inflammatory bowel disease in the M\u0101ori population of New Zealand. Internal Medicine Journal. 2024;54:1541\u20131547.","journal-title":"Internal Medicine Journal."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08811-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:40:45Z","timestamp":1739990445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08811-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["8811"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08811-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"9 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Angela Forbes receives a Department of Medicine PhD scholarship. Professor Andrew Day\u2019s research is supported by Cure Kids. Professor Chris Frampton has no financial disclosures. Professor Richard Gearry has sat on advisory boards, speaker\u2019s bureaus, or received research funding from AbbVie, Janssen, Pharmaco, Takeda, and Zespri.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This research was approved by the University of Otago Human Research Ethics Committee reference HD23\/098.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}